Method using a ret fusion gene as a biomarker to select non-small cell lung cancer (nsclc) and thyroid cancer patients for a cancer treatment

作者: Kaoru Tanaka , Kunio Okamoto , Kazuko Sakai , Toshio Shimizu , Kazuhiko Nakagawa

DOI:

关键词:

摘要: The present invention relates to a RET fusion gene such as CCDC6-RET biomarker monitor the activity of compound 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone or pharmaceutically acceptable salt thereof, and especially its monoethanesulphonate form, when used alone optionally in combination with further active ingredients and/or treatments. also specific uses said treatment cancers.

参考文章(7)
Matthew J. Hawryluk, Sean R. Downing, Doron Lipson, Alexander N. Parker, Philip James Stephens, Novel kif5b-ret fusion molecules and uses thereof ,(2012)
Makito Suzuki, Hideki Makinoshima, Shingo Matsumoto, Ayako Suzuki, Sachiyo Mimaki, Koutatsu Matsushima, Kiyotaka Yoh, Koichi Goto, Yutaka Suzuki, Genichiro Ishii, Atsushi Ochiai, Koji Tsuta, Tatsuhiro Shibata, Takashi Kohno, Hiroyasu Esumi, Katsuya Tsuchihara, Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo. Cancer Science. ,vol. 104, pp. 896- 903 ,(2013) , 10.1111/CAS.12175
Daisuke Matsubara, Yoshihiko Kanai, Shumpei Ishikawa, Shiori Ohara, Taichiro Yoshimoto, Takashi Sakatani, Sachiko Oguni, Tomoko Tamura, Hiroaki Kataoka, Shunsuke Endo, Yoshinori Murakami, Hiroyuki Aburatani, Masashi Fukayama, Toshiro Niki, Identification of CCDC6-RET Fusion in the Human Lung Adenocarcinoma Cell Line, LC-2/ad Journal of Thoracic Oncology. ,vol. 7, pp. 1872- 1876 ,(2012) , 10.1097/JTO.0B013E3182721ED1
Norbert Schweifer, Martin Steegmaier, Flavio Solca, Frank Hilberg, Wolfgang Sommergruber, Norbert Kraut, Wolfgang Rettig, Treatment of cancer ,(2006)